TLR2 and TLR4 Genes Expression Analysis : A Hopeful Approach To Recognition Causes of Essential Hypertension

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 472

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CIGS15_645

تاریخ نمایه سازی: 13 بهمن 1398

Abstract:

Background: Cardiovascular diseases (CVD) refer to a group of life threating disorders that affect heart and circulatory system. As a main risk factor, essential hypertension is the most common cause of damages. Previous studies showed different pathways contribute to pathogenesis of hypertension. Among them, inflammatory pathways, particularly immune receptors, due to their important role, need more attention to research. In the other hand, the exact cause of hypertension is not clear, Therefore, in this study we aimed to evaluate TLR2 and TLR4 genes expression in primary hypertensive patients compared with healthy controls.Methods: 50 hypertensive patients and 50 healthy controls (35-65 years old) without any drug consumption and inflammatory disorders participated in this study. peripheral blood obtained and TLR2 and TLR4 genes expression measured by Real-time PCR.Results: TLR2 gene expression up regulated in 36% of patients compared with healthy controls but it was not statistically significant. About TLR4, statistically significant up regulation was observed (P< 0.001).Discussion: Up regulation of innate immunity receptors indicates undeniable role of this pathway in pathogenesis of hypertension and CVD. Our findings suggest that, these pathways can be a suitable candidate for control and treatment of hypertension.

Authors

Fatemeh Kharaie

Department of medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran;

Mohammad Shekari

Department of medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran;

Abdolazim Nejatizadeh

Department of medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran;

Eghbal Eftekhari Tasnim

Molecular medicine research Center, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Elahe Farahbakhsh

Department of medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran;

Fatemeh Nabizadeh

Department of medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran;